{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.157G>A",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "A",
            "position": "157"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T mutation in alpha-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "2D Difference Gel Electrophoresis (2D-DIGE)",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "Differentiated human SH-SY5Y dopaminergic cells overexpressing WT or A53T alpha-synuclein were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Minimal effect on mitochondrial protein expression levels compared to WT alpha-synuclein; only 7 out of 34 identified protein spots significantly differentially expressed in the A53T group."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Four replicates each of control, A53T, and WT groups in the pH 4-7 range and three replicates in the pH 6-11 range."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Internal standard prepared by pooling equal quantities of protein extract from each experimental cell type."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Host SH-SY5Y cells without overexpression of alpha-synuclein used as control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA (p < 0.01) across all groups (host, WT, A53T) followed by independent t-tests."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Protein expression fold change less than 1.8 or greater than -1.8 compared to control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Protein expression fold change greater than 1.8 or less than -1.8 compared to control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western Blot Analysis",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "Mitochondrial extracts from differentiated SH-SY5Y cells expressing WT or A53T alpha-synuclein were analyzed."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Confirmed altered expression levels of mitochondrial proteins (HSPA9, NDUFS1, DLAT) in A53T alpha-synuclein cells, though effects were less pronounced compared to WT."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three consecutive passages of cell extracts were run in parallel for each sample type."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in duplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Host control cells used for normalization."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Optical density values calculated as a percentage of the mean signal generated by control cells."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Expression levels comparable to mean control group values.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant deviation from mean control group values (based on standard deviation).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "OXPHOS Complex I Activity and Quantity Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "Mitochondria prepared from triplicate passages of differentiated SH-SY5Y cells expressing WT or A53T alpha-synuclein."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.157G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Marginally reduced OXPHOS complex I specific activity in A53T overexpressing cell lines compared to host cells."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Triplicate passages of each cell type analyzed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Analyzed twice from each passage."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Vector control cells (pcDNA6) used as baseline."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Independent t-tests (threshold at p < 0.05) to determine statistical significance."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "OXPHOS complex I activity comparable to control group mean values.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant reduction in OXPHOS complex I activity (p < 0.05) compared to control group.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}